KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

Trading levels for AVRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.25 3.03 %
R2 1.23 1.61 %
R1 1.22 0.732 %
Current price: 1.21
Support S1 1.18 -2.11 %
S2 1.17 -2.99 %
S3 1.16 -4.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.31 8.26 %
R2 1.30 7.44 %
R1 1.26 4.13 %
Current price 1.21
Support S1 1.19 -1.65%
S2 1.19 -2.07%
S3 1.15 -4.96%

AVRO Predictions History

2 years ago
JS predicted that AVRO for 2022-04-11 is going $1.18 (2.61%)

2 years ago
alexkkeen.254043 predicted that AVRO for 2022-04-11 is going

Rank:

3 years ago
JS predicted that AVRO for 2021-03-17 is going $13.76 (0.44%)

3 years ago
Jon Graham predicted that AVRO for 2021-03-17 is going $10.83 (-20.95%)

Rank:

3 years ago
JS predicted that AVRO for 2021-02-16 is going $15.51 (-3.84%)

3 years ago
Jon Graham predicted that AVRO for 2021-02-16 is going $16.80 (4.15%)

Rank:

3 years ago
JS predicted that AVRO for 2020-10-26 is going $16.44 (1.61%)

3 years ago
iHustle84 predicted that AVRO for 2020-10-26 is going $18.89 (16.75%)

Click to get the best stock tips daily for free!

About AVROBIO Inc

AVROBIO AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry di... AVRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT